Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-29

Clinical Trial Update: Albumin for Intracerebral Hemorrhage Intervention [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating albumin for intracerebral hemorrhage was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albumin

Snippet

Sponsor: Georgetown University | Conditions: Intracerebral Hemorrhage | Phase 2 | Status: TERMINATED | Results posted: 2014-08-29